Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial.
Saved in:
| Title: | Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial. |
|---|---|
| Authors: | Paller AS; Walter J. Hamlin Professor of Dermatology and Chair, Departments of Dermatology and Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. apaller@northwestern.edu., Cork MJ; Sheffield Children's NIHR Commercial Research Delivery Centre, Sheffield, UK.; Sheffield Dermatology Research, Division of Clinical Medicine, University of Sheffield Medical School, Sheffield, UK., Hong HC; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, Canada., Soong W; AllerVie Health-Alabama Allergy & Asthma Center, Birmingham, AL, USA., Schneider SKR; LEO Pharma Inc., Madison, NJ, USA., Lo H; LEO Pharma Inc., Madison, NJ, USA., Vinther F; LEO Pharma A/S, Ballerup, Denmark., Thøgersen P; LEO Pharma A/S, Ballerup, Denmark., Wollenberg A; Department of Dermatology and Allergy, Augsburg University Hospital, Augsburg, Germany.; Department of Dermatology and Allergy, Ludwig Maximilian University of Munich, Munich, Germany.; Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany. |
| Source: | Dermatology and therapy [Dermatol Ther (Heidelb)] 2026 Jun; Vol. 16 (6), pp. 3037-3048. Date of Electronic Publication: 2026 Apr 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42033591 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Paller+AS%22">Paller AS</searchLink>; Walter J. Hamlin Professor of Dermatology and Chair, Departments of Dermatology and Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. apaller@northwestern.edu.<br /><searchLink fieldCode="AU" term="%22Cork+MJ%22">Cork MJ</searchLink>; Sheffield Children's NIHR Commercial Research Delivery Centre, Sheffield, UK.; Sheffield Dermatology Research, Division of Clinical Medicine, University of Sheffield Medical School, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Hong+HC%22">Hong HC</searchLink>; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Soong+W%22">Soong W</searchLink>; AllerVie Health-Alabama Allergy & Asthma Center, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Schneider+SKR%22">Schneider SKR</searchLink>; LEO Pharma Inc., Madison, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Lo+H%22">Lo H</searchLink>; LEO Pharma Inc., Madison, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Vinther+F%22">Vinther F</searchLink>; LEO Pharma A/S, Ballerup, Denmark.<br /><searchLink fieldCode="AU" term="%22Thøgersen+P%22">Thøgersen P</searchLink>; LEO Pharma A/S, Ballerup, Denmark.<br /><searchLink fieldCode="AU" term="%22Wollenberg+A%22">Wollenberg A</searchLink>; Department of Dermatology and Allergy, Augsburg University Hospital, Augsburg, Germany.; Department of Dermatology and Allergy, Ludwig Maximilian University of Munich, Munich, Germany.; Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101590450%22">Dermatology and therapy</searchLink> [Dermatol Ther (Heidelb)] 2026 Jun; Vol. 16 (6), pp. 3037-3048. <i>Date of Electronic Publication: </i>2026 Apr 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Healthcare+Communications%22">Springer Healthcare Communications </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101590450 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8210 (Print) <i>NLM ISO Abbreviation: </i>Dermatol Ther (Heidelb) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42033591 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s13555-026-01745-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3037 Titles: – TitleFull: Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Paller AS – PersonEntity: Name: NameFull: Cork MJ – PersonEntity: Name: NameFull: Hong HC – PersonEntity: Name: NameFull: Soong W – PersonEntity: Name: NameFull: Schneider SKR – PersonEntity: Name: NameFull: Lo H – PersonEntity: Name: NameFull: Vinther F – PersonEntity: Name: NameFull: Thøgersen P – PersonEntity: Name: NameFull: Wollenberg A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2193-8210 Numbering: – Type: volume Value: 16 – Type: issue Value: 6 Titles: – TitleFull: Dermatology and therapy Type: main |
| ResultId | 1 |
